Congratulations to our team at Clinipace Worldwide on a great year! The company announced today we have closed our strongest year to date, with a record number of new clinical development projects and regulatory and strategic development engagements; driving 114% growth in bookings compared to the previous year.
Much of our success in 2013 can be attributed to new client acquisition within both the Clinical and Regulatory divisions, as well as strong demand for additional projects within our existing base of clients.
2013 by the numbers:
- 63% year-over-year growth in consolidated revenues
- 194% year-over-year growth in new bookings for full-service dCRO studies
- Tripling of average contract value
- 42% backlog growth
- 2.0 book-to-bill ratio
- 50 net new hires
Jeff Williams, CEO, commented, “The continued growth in both new client acquisition and follow-on projects from existing clients demonstrates the level of trust and partnership we build with our clients. We work hard to forge a real partnership with our clients and to provide efficiency and visibility into study and program management through our dCRO model.”